Lata Suman, Kumari Sandhya, Das Ram, Pasi Shweta, Dhiman Ramesh C
ICMR-National Institute of Malaria Research, Dwarka Sector 8, New Delhi, 11007, India.
Indira Gandhi Medical College and Hospital, Shimla, 171001, Himachal Pradesh, India.
Heliyon. 2021 Jun 11;7(6):e07282. doi: 10.1016/j.heliyon.2021.e07282. eCollection 2021 Jun.
Visceral leishmaniasis (VL) is in elimination phase in India while cutaneous leishmaniasis (CL) is being reported from new foci. In Himachal Pradesh (HP), a foci of CL had been reported along Satluj River, but the causative agent poses a dilemma, hence the present study was undertaken in Shimla, Kullu and Kinnaur districts.
A total of 28 CL patients from Indira Gandhi Medical College and Hospital Shimla (IGMC) in 2018, were tested by rK39., Twelve fresh cases were subjected to microscopic detection of parasite, PCR and sequencing. Skin biopsies of 3-4 mm diameter were cultured, as well as imprints were prepared for the detection of amastigotes. Biopsy samples were inoculated into different culture media (M199, RPMI 1640, NNN) and were incubated at 22-24 °C. Polymerase chain reaction (PCR) was performed to characterize parasite species.
Of 28 patients, one was positive by rK39 dipstick test and one imprint was found positive for amstigotes. Twelve biopsy DNA samples subjected to PCR for kDNA, were found positive. Identification of species was confirmed by PCR-RFLP and sequencing method. Of 12 positive samples, six were identified as , three , two and one remained unidentified.
This study revealed the existence of three species of parasites i.e., indicating the existence of typical and atypical leishmaniasis in Himachal Pradesh. The occurrence of CL cases in HP, Kerala or elsewhere should not be ignored considering them just cases of CL alone. Further studies are warranted to confirm the existence of zymodeme MON37 from cases of CL in HP or zymodeme MON2 strain causing VL in Bihar. Elimination of CL should also be considered along with goal of Kala -Azar elimination.
内脏利什曼病(VL)在印度正处于消除阶段,而皮肤利什曼病(CL)不断有新疫源地被报告。在喜马偕尔邦(HP),萨特卢杰河沿岸曾报告有CL疫源地,但病原体存在争议,因此本研究在西姆拉、库鲁和金瑙尔地区开展。
2018年,对来自西姆拉英迪拉·甘地医学院和医院(IGMC)的28例CL患者进行了rK39检测。12例新发病例接受了寄生虫显微镜检测、PCR和测序。对直径3 - 4毫米的皮肤活检组织进行培养,并制作印片以检测无鞭毛体。将活检样本接种到不同培养基(M199、RPMI 1640、NNN)中,在22 - 24°C下孵育。进行聚合酶链反应(PCR)以鉴定寄生虫种类。
28例患者中,1例rK39试纸条检测呈阳性,1张印片发现无鞭毛体呈阳性。12份活检DNA样本进行kDNA的PCR检测,均呈阳性。通过PCR - RFLP和测序方法确认了种类鉴定。12份阳性样本中,6份鉴定为,3份,2份,1份仍未鉴定。
本研究揭示了三种寄生虫的存在,即表明喜马偕尔邦存在典型和非典型利什曼病。不应仅将HP、喀拉拉邦或其他地方的CL病例视为单纯的CL病例而予以忽视。有必要进一步研究以确认HP的CL病例中是否存在zymodeme MON37或比哈尔邦导致VL的zymodeme MON2菌株。在实现消除黑热病目标的同时,也应考虑消除CL。